Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc sell StockNews.com

Start price
€4.51
28.09.24 / 50%
Target price
-
28.09.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 28.09.25. The prediction end date can be changed by StockNews_com at any time.
Performance without dividends (%)
Name 1w
Corvus Pharmaceuticals Inc -
iShares Core DAX® 3.523%
iShares Nasdaq 100 1.026%
iShares Nikkei 225® -0.063%
iShares S&P 500 0.557%

Comments by StockNews_com for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CRVS provided by MarketBeat

Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.92
03.04.23
-
03.04.24
81.96%
04.04.24

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.65
26.03.23
-
26.03.24
144.58%
27.03.24

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.68
18.03.23
-
18.03.24
157.58%
19.03.24